COAG — Hemab Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Brief: Hemab Therapeutics Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Biotech firm Odyssey raises $279 million in upsized US IPO (updated)
NASDAQ RESUMED AT 12:30 PM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Hemab Therapeutics Prices Upsized IPO Of 16,750,000 Shares At $18.00 Per Share